Chemical Structure (Segluromet 01)
Segluromet Tablet, Film Coated
Product Images NDC 0006-5374
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Segluromet (NDC 0006-5374). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Segluromet 02)
Figure 1 (Segluromet 03)
This text appears to be a list of medications with their respective doses. It also includes numerical values for Auc, Cmax, and Geometric Mean Ratio. However, there is not enough information to determine the purpose or context of these values.*
Figure 2 (Segluromet 04)
This appears to be a list of medications and doses, followed by some sort of comparison between them. The medications listed are Sitagliptin (100 mg single dose), Metformin (1000 mg single dose), Glimepiride (1 mg single dose), and Simvastatin (40 g single dose). There are also some measurements listed, including Auc, Cmax, and a geometric mean ratio with a 90% confidence interval. There is no clear context provided, so it is difficult to determine the purpose of this information.*
Figure 3 (Segluromet 05)
Principal Display Panel (2.5 mg/500 mg Tablet Bottle Label)
Segluromet is a medication available in tablet form with 2.5mg of ertugiflozin and 500mg of metformin HCl. The accompanying medication guide should be given to each patient. Each tablet contains 3.4 mg ertugiflozin L and 0mg of medominydchioe. The item is manufactured by MERCK and has 60 tablets per container. The usual dosage should be consulted on the package. The rest of the text appears to be mostly formatting and encoding information.*
Principal Display Panel (2.5 mg/1,000 mg Tablet Bottle Label)
Segluromet A is a medication available in tablet form, with each tablet containing 2.5mg of ertugliflozin and 1000mg of metformin hydrochloride. The medication guide must be dispensed to each patient, and the usual dosage is available on the packaging. The text also includes a National Drug Code (NDC) and other related codes for identification purposes.*
Principal Display Panel (7.5 mg/500 mg Tablet Bottle Label)
Segluromet is a medication that comes in the form of tablets containing 7.5mg of ertugliflozin and 500mg of metformin hydrochloride. Each tablet contains 971mg of ertugliflozin-glycine and is sold in packages of 60 tablets. It is a prescription medication and should be dispensed to patients along with the accompanying Medication Guide. The encoding area contains a space reserved for 2D Serialization Barcode, Serial Number, Expiry, and Lot.*
Principal Display Panel (7.5 mg/1,000 mg Tablet Bottle Label)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
